Zelira Therapeutics Limited reported earnings results for the full year ended June 30, 2022. For the full year, the company reported sales was AUD 1.54 million compared to AUD 0.663316 million a year ago. Net loss was AUD 11.95 million compared to AUD 8.55 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.52 AUD | -13.33% | -23.53% | -42.22% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-42.22% | 4.5M | |
+4.03% | 111B | |
+11.43% | 105B | |
-12.67% | 22.34B | |
-3.70% | 21.93B | |
-6.03% | 18.59B | |
-35.21% | 18.12B | |
-10.29% | 16.96B | |
+2.37% | 13.7B | |
+36.28% | 12.45B |
- Stock Market
- Equities
- ZLD Stock
- News Zelira Therapeutics Limited
- Zelira Therapeutics Limited Reports Earnings Results for the Full Year Ended June 30, 2022